Paper37510296
The Current State of Charcot-Marie-Tooth Disease Treatment.
Okamoto Y and 1 other. Genes (Basel), 2023. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. The Current State of Charcot-Marie-Tooth Disease Treatment. Papers, record 37510296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37510296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Charcot-Marie-Tooth Disease | Major topic |
| Humans | |
| Mutation | |
| Intracellular Space | |
| Calcium | |
| Gene Silencing | |
| Genetic Therapy | |
| Animals | |
| Myelin P0 Protein |
Source PubMed
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22966146 | Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. | Ann Rheum Dis | 2012 | https://conductscience.org/library/papers/22966146 | PubMed |
| 2 | 26739777 | Development of curcumin-cyclodextrin/cellulose nanocrystals complexes: New anticancer drug delivery systems. | Bioorg Med Chem Lett | 2016 | https://conductscience.org/library/papers/26739777 | PubMed |
| 3 | 16252242 | Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. | Am J Hum Genet | 2005 | https://conductscience.org/library/papers/16252242 | PubMed |
| 4 | 23847051 | Curcumin facilitates a transitory cellular stress response in Trembler-J mice. | Hum Mol Genet | 2013 | https://conductscience.org/library/papers/23847051 | PubMed |
| 5 | 33542455 | AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1. | Gene Ther | 2022 | https://conductscience.org/library/papers/33542455 | PubMed |
| 6 | 29674596 | MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. | Science | 2018 | https://conductscience.org/library/papers/29674596 | PubMed |
| 7 | 15937340 | Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15937340 | PubMed |
| 8 | 29771329 | Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancer. | Hum Mol Genet | 2018 | https://conductscience.org/library/papers/29771329 | PubMed |
| 9 | 29036910 | Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children. | Molecules | 2017 | https://conductscience.org/library/papers/29036910 | PubMed |
| 10 | 25150498 | Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. | Nat Med | 2014 | https://conductscience.org/library/papers/25150498 | PubMed |
| 11 | 27530546 | An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0. | Neurosci Lett | 2016 | https://conductscience.org/library/papers/27530546 | PubMed |
| 12 | 25614874 | The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy. | Mol Genet Genomic Med | 2014 | https://conductscience.org/library/papers/25614874 | PubMed |
| 13 | 19320048 | Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease. | Neurobiol Dis | 2009 | https://conductscience.org/library/papers/19320048 | PubMed |
| 14 | 29998508 | Genetic and phenotypic profile of 112 patients with X-linked Charcot-Marie-Tooth disease type 1. | Eur J Neurol | 2018 | https://conductscience.org/library/papers/29998508 | PubMed |
| 15 | 5652992 | Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. | Arch Neurol | 1968 | https://conductscience.org/library/papers/5652992 | PubMed |
| 16 | 32147437 | HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice. | Exp Neurol | 2020 | https://conductscience.org/library/papers/32147437 | PubMed |
| 17 | 20739560 | Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice. | J Neurosci | 2010 | https://conductscience.org/library/papers/20739560 | PubMed |
| 18 | 17296794 | Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. | J Cell Biol | 2007 | https://conductscience.org/library/papers/17296794 | PubMed |
| 19 | 27799291 | Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination. | EMBO Mol Med | 2016 | https://conductscience.org/library/papers/27799291 | PubMed |
| 20 | 16157899 | NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. | Neurology | 2005 | https://conductscience.org/library/papers/16157899 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42799012 | Pathogenic LRSAM1 RING Domain Variants Disrupt Intracellular Protein Localization in Charcot-Marie-Tooth Disease Type 2P. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42799012 | PubMed |
| 42653481 | Tyrosine Supplementation Rescues a Growth Defect in a Humanized S. cerevisiae Model of YARS1 Associated with CMT-DI. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653481 | PubMed |
| 42522265 | A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot-Marie-Tooth disease type 1. | Stem Cells Transl Med | 2026 | https://conductscience.org/library/papers/42522265 | PubMed |
| 42278657 | Control of Schwann Cell Myelination by DDR1 Receptor Tyrosine Kinase. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278657 | PubMed |
| 41981429 | [Clinical application research of three-dimensional printed patient-specific cutting guides in Cole midfoot osteotomy]. | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | 2026 | https://conductscience.org/library/papers/41981429 | PubMed |
| 41828558 | Contemporary Strategies of Gene and Cell Therapy in the Treatment of Peripheral Nervous System Injuries and Disorders. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828558 | PubMed |
| 41820622 | Gene-sized editing for the therapy of genetic diseases. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/41820622 | PubMed |
| 41757265 | Case Report: Recurrent stroke-like episodes triggered by high-altitude exposure in X-linked charcot-marie-tooth disease. | Front Genet | 2026 | https://conductscience.org/library/papers/41757265 | PubMed |
| 41752078 | AAVrh74.tMCK.NT-3 Surrogate Gene Therapy in a Mouse Model of CMT2A. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752078 | PubMed |
| 41750400 | ABCA1: A Therapeutic Target for Improving Cholesterol Homeostasis in Peripheral Neuropathies. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750400 | PubMed |
| 41617474 | A qualitative study of enablers and barriers to healthy eating in adults with Charcot Marie Tooth disease using the Theoretical Domains Framework and COM-B model. | J Health Psychol | 2026 | https://conductscience.org/library/papers/41617474 | PubMed |
| 41507260 | Metabolic signatures in sciatic nerve of PMP22 transgenic rats provide insights into the pathogenesis of charcot-marie-tooth disease type 1 A. | Sci Rep | 2026 | https://conductscience.org/library/papers/41507260 | PubMed |
| 40831607 | Modeling of Charcot-Marie-Tooth disease in zebrafish. | Front Mol Neurosci | 2025 | https://conductscience.org/library/papers/40831607 | PubMed |
| 40710385 | Effectiveness and Clinical Outcomes of PGT-M Using Karyomapping for Successful Pregnancy and Birth in Various Types of Charcot-Marie-Tooth Disease. | J Pers Med | 2025 | https://conductscience.org/library/papers/40710385 | PubMed |
| 40406921 | Mitochondria-Associated Membranes: A Key Point of Neurodegenerative Diseases. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40406921 | PubMed |
| 39937093 | Talar Morphology of Charcot-Marie-Tooth Patients With Cavovarus Feet. | Foot Ankle Int | 2025 | https://conductscience.org/library/papers/39937093 | PubMed |
| 39795872 | A Role of Inflammation in Charcot-Marie-Tooth Disorders-In a Perspective of Treatment? | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39795872 | PubMed |
| 39748939 | Electrical storm in a patient with Charcot-Marie-Tooth disease treated with radiofrequency ablation and subsequent serious complication of implantable cardioverter defibrillator implantation: a case report. | Eur Heart J Case Rep | 2025 | https://conductscience.org/library/papers/39748939 | PubMed |
| 39456965 | Evaluation of the Role of Tanshinone I in an In Vitro System of Charcot-Marie-Tooth Disease Type 2N. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456965 | PubMed |
| 39328666 | A Case of Charcot-Marie-Tooth Disease Causing Colitis and Electrolyte Imbalances. | Cureus | 2024 | https://conductscience.org/library/papers/39328666 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37510296
GET https://conductscience.org/api/papers/v1/37510296/references?page=2